Literature DB >> 28382704

Hepatitis E: the current state of play.

M J Ankcorn1,2, R S Tedder1,2.   

Abstract

The hepatitis E virus (HEV) is a major cause of acute hepatitis globally. Genotypes 1 and 2 (G1 and G2) are obligate human pathogens transmitted faeco-orally, leading to epidemics in developing countries. In contrast, genotypes 3 and 4 (G3 and G4) have a wider host range, including humans, but are primarily porcine viruses and are transmitted from animals to humans as a food-borne zoonosis when meat from an infected animal is consumed. HEV is increasingly recognised as a problem in developed countries, including countries in Europe. G3 HEV is now the most common cause of acute viral hepatitis in the UK and cases continue to rise. The majority of these infections are acquired within the UK and thought to be from insufficiently cooked meat, predominantly processed pork meat. Previously thought to only cause self-limiting disease, HEV infection can persist in immunosuppressed patients, which may lead to chronic hepatitis and the rapid development of cirrhosis. Of particular interest to the transfusion community has been the possibility of transfusion-transmitted HEV, which has been reported from countries classically considered HEV-endemic but also non-endemic countries in Europe and Japan. This has prompted some countries to introduce screening for HEV in blood donations.
© 2017 British Blood Transfusion Society.

Entities:  

Mesh:

Year:  2017        PMID: 28382704     DOI: 10.1111/tme.12405

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  12 in total

1.  Seroprevalence of hepatitis E virus among blood donors in northern Italy (Sondrio, Lombardy) determined by three different assays.

Authors:  Cristina Galli; Laura Fomiatti; Catia Tagliacarne; Claudio Velati; Alessandro R Zanetti; Silvana Castaldi; Luisa Romanò
Journal:  Blood Transfus       Date:  2017-10       Impact factor: 3.443

2.  Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.

Authors:  John R Ticehurst; Nora Pisanic; Michael S Forman; Carly Ordak; Christopher D Heaney; Edgar Ong; Jeffrey M Linnen; Paul M Ness; Nan Guo; Hua Shan; Kenrad E Nelson
Journal:  Transfusion       Date:  2019-01-31       Impact factor: 3.157

Review 3.  Epidemiology and Transmission of Hepatitis A Virus and Hepatitis E Virus Infections in the United States.

Authors:  Megan G Hofmeister; Monique A Foster; Eyasu H Teshale
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

4.  HEV ORF3 downregulates TLR7 to inhibit the generation of type I interferon via impairment of multiple signaling pathways.

Authors:  Qingsong Lei; Lin Li; Shujun Zhang; Tianju Li; Xiaomei Zhang; Xiaolin Ding; Bo Qin
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

5.  High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.

Authors:  Yue Feng; Yue-Mei Feng; Songmei Wang; Fang Xu; Xuehui Zhang; Chunyue Zhang; Yuanyuan Jia; Wanru Yang; Xueshan Xia; Jianzhong Yin
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

6.  High sensitivity of domestic pigs to intravenous infection with HEV.

Authors:  Lisa Dähnert; Martin Eiden; Josephine Schlosser; Christine Fast; Charlotte Schröder; Elke Lange; Albrecht Gröner; Wolfram Schäfer; Martin H Groschup
Journal:  BMC Vet Res       Date:  2018-12-04       Impact factor: 2.741

7.  Different Outcomes of Experimental Hepatitis E Virus Infection in Diverse Mouse Strains, Wistar Rats, and Rabbits.

Authors:  Josephine Schlosser; Lisa Dähnert; Paul Dremsek; Kerstin Tauscher; Christine Fast; Ute Ziegler; Albrecht Gröner; Rainer G Ulrich; Martin H Groschup; Martin Eiden
Journal:  Viruses       Date:  2018-12-20       Impact factor: 5.048

8.  Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.

Authors:  Jens Dreier; Cornelius Knabbe; Tanja Vollmer
Journal:  Front Med (Lausanne)       Date:  2018-02-01

9.  Prevalence and 9-year incidence of hepatitis E virus infection among North Italian blood donors: Estimated transfusion risk.

Authors:  Marta Spreafico; Livia Raffaele; Irene Guarnori; Barbara Foglieni; Alessandra Berzuini; Luca Valenti; Alessandro Gerosa; Agostino Colli; Daniele Prati
Journal:  J Viral Hepat       Date:  2020-04-08       Impact factor: 3.728

10.  Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016.

Authors:  Christoph Niederhauser; Nadja Widmer; Magdalena Hotz; Caroline Tinguely; Stefano Fontana; Gabrielle Allemann; Mauro Borri; Laura Infanti; Amira Sarraj; Jörg Sigle; Michèle Stalder; Jutta Thierbach; Sophie Waldvogel; Tina Wiengand; Max Züger; Peter Gowland
Journal:  Euro Surveill       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.